Ultrastructural analysis of germinal centers in lymph nodes of patients with HIV-1-induced persistent generalized lymphadenopathy: evidence for persistence of infection. 1989

K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic

Germinal centers play an important role in the pathogenesis of HIV-1-induced lymphadenopathy. Cell-free retrovirus particles, gag proteins of HIV-1, and cells expressing viral RNA can be detected in these areas of the lymph node. In the present study, the ultrastructural changes and the interactions of virus with different cell types of the germinal centers were investigated. We compared the alterations of lymph nodes obtained shortly after seroconversion with those seen in longstanding lymphadenopathy. The results demonstrated that germinal centers were already infected in the early phase of the disease. However, the number of cell free virions was low. During the course of the disease, large amounts of cell free virions accumulated in the germinal centers. The persistence of germinal center infection for up to 2 years was demonstrated by detecting retrovirus particles in repeated biopsy specimens. In addition, the presence of numerous small, moderately electron dense structures that might represent defective particles of HIV-1 and influence the course of the disease were described. HIV-1 was found to replicate in lymphocytes, macrophages, and follicular dendritic cells. Quite possibly, a genomic shift may occur at the time of transmission of the virus to a novel target cell, thus, germinal centers may be one of the anatomic sites where HIV-1 acquires the ability to develop into a variant with preferential tropism for a given cell type.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000386 AIDS-Related Complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. ARC,Lymphadenopathy Syndrome,AIDS Related Complex,Complex, AIDS-Related,Lymphadenopathy Syndromes,Syndrome, Lymphadenopathy,Syndromes, Lymphadenopathy
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
January 1985, Diagnostic immunology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
January 1988, The New England journal of medicine,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
January 1990, Progress in AIDS pathology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
February 1992, Clinical immunology and immunopathology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
April 1988, Human pathology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
July 1987, American journal of clinical pathology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
August 1985, American journal of clinical pathology,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
January 1990, La Ricerca in clinica e in laboratorio,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
July 2021, Current opinion in HIV and AIDS,
K Tenner-Rácz, and P Rácz, and S Gartner, and J Ramsauer, and M Dietrich, and J C Gluckman, and M Popovic
April 1969, Journal of the Reticuloendothelial Society,
Copied contents to your clipboard!